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PURPOSE: Treatment with curettage, cauterization, and methylmethacrylate of aggressive benign bone lesions is a method now
widely accepted in most orthopedic oncology centers. However, one of the controversies regarding this technique is the possible
complications that may arise from the use of methylmethacrylate, which has caused some authors to remove it 2 years after the
surgery and replace it with bone graft. The objective of this paper is to present a functional and radiographic evaluation of 214
patients presenting with aggressive benign bone lesions treated with curettage, cauterization, and methylmethacrylate from 1974
to 1998, with some of them having 24 years of follow-up. These patients were clinically and radiographically evaluated for the
incidence of late osteoarthrosis, range of motion, and pain in the involved joint.
METHOD: This study comprised 214 patients, with an average follow-up duration of 10.6 years (range : 2 to 24 years. All cases
involved aggressive benign lesions. The patients were evaluated according to the Musculoskeletal Tumor Society Score (MSTS)
functional evaluation system, and the complications are described.
RESULTS: The MSTS functional evaluation was excellent in 166 cases (78%), good in 26 (12%), fair in 11 (5%), and poor in 11
(5%). The following complications were observed: late osteoarthrosis, 25 cases (12%); infection, 12 (6%); pathologic fracture, 11
(5%); and local recurrence, 19 (9%).
CONCLUSION: Based on clinical assessment, no significant deleterious effects directly related to the use of methylmethacrylate
were observed. The functional evaluation performed in 1998 (up to 24 years of follow-up) did not show significant change when
compared to the evaluation performed in 1985.
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Although many authors1–10 have already demonstrated
the good results of curettage and methylmethacrylate in the
treatment of giant cell tumors and other aggressive benign
bone lesions, we are not aware of any report on large se-
ries of cases with long-term evaluation discussing possi-
ble deleterious effects of the cement, as most of these le-
sions occur close to weight-bearing joints. Many factors
have contributed to the increased use of bone cement as
an adjuvant in the treatment of these lesions, such as less
surgical morbidity, early recurrence detection, minimal
functional deficit, and a lower recurrence rate.
Although there is some concern that the heat generated
by the methylmethacrylate may lead to tumor necrosis, 11-
12
 the recurrence rate observed in most oncology orthoped-
ics services is around 9%.3 Other types of local adjuvants
have been employed separately or in association with the
cement, such as liquid nitrogen12,13 and phenol,8 which is
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also associated with a low rate of recurrence but with a
higher morbidity. We have routinely used meticulous cau-
terization of the cavity along with cement to enhance the
destruction of the tumor cells.
The objective of this work is to present the functional
results during long-term follow-up of up to 24 years for
214 patients presenting with aggressive benign bone lesions
treated by the same team of surgeons using the same
method. These patients were clinically and radiographically
re-evaluated for the occurrence of late degenerative
changes, progressive loss of range of motion, and pain in
the affected joint.
MATERIALS AND METHODS
This study comprises 214 patients treated at the Depart-
ment of Orthopedics of Hospital das Clinicas, Faculty of
Medicine, University of São Paulo, between 1974 and 1998,
with confirmed histological diagnosis of benign aggressive
bone tumors of the following types: 135 giant cell tumors,
38 aneurysmal bone cyst, 22 chondroblastomas, 10
chondromyxoid fibromas, and 9 osteoblastomas. Patient
ages ranged from 2 to 63 years with an average of 30.6
years.
Of the 214 patients, 115 were male and 99 female
(Figure 1). The average follow-up time was 10.6 years,
ranging from 2 to 24 years. The anatomical sites involved
were as follows: distal femur (99 cases), proximal tibia
(50), distal radius (24), proximal femur (15), distal tibia
(8), proximal humerus (6), distal humerus (4), sacrum (4),
and phalanges (4) (Figure 2).
All lesions were classified according to the system of
Campanacci et al.14 for giant cell tumors as follows: 86
grade I (intraosseous), 103 grade II (cortical thinning); and
25 grade III (cortical rupture) (Figure 3). The criterion for
employing this treatment method, including grade III le-
sions, was the presence of at least 2 walls of the cavity still
intact.
Operative Technique
The surgical procedure did not change from our previ-
ous publications with the following exception: since 1986,
we have not been using a polyethylene piece fitted accord-
ing to the size of the lesion to fill the cavity, as can be noted
for cases with longer follow-up (Figure 4). It is important
to emphasize that we also performed the cauterization of
the whole surface after meticulous curettage and then used
a high-speed burr as a second local adjuvant. After this pro-
cedure, the cavity was rinsed again, and the methyl-
methacrylate bone cement was packed under pressure into
the cavity, making certain that no empty space was left.
We did not protect the articular cartilage. To decrease the
risk of pathologic fracture in larger defects with cortical
destruction, we inserted intramedullary Ender nails before
applying the cement.
After the fifth year of surgery, all patients were followed
postoperatively on an annual basis with clinical exams and
plain x-rays to determine whether the Musculoskeletal Tumor
Society Score (MSTS) functional evaluation system revealed
any significant change in terms of pain, loss of joint mobil-
ity, or degenerative changes visible in plain radiographs,
when compared to the functional evaluation of 1985.
Figure 3 - Campanacci Grade
Figure 2 - Localization
Figure 1 - Gender
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Inclusion Criteria
1. Patients with B3 aggressive benign bone tumor
proven by radiographic and histologic evaluation and by
rapid growth within weeks.
2. No involvement, as yet, of the joint adjacent to the
tumor, thus allowing the use of a marginal resection tech-
nique rather than ample resection and placement of an
endoprosthesis.
3. Absence of any histologic evidence of a malignant
neoplasm.
Exclusion Criteria
1. Patients with B1 or B2 nonaggressive benign tumors
that did not justify the use of a local adjuvant—ie, a case
for which a bone graft could be used with no risk of local
recurrence.
2. Significant destruction of the adjoining joint, with
injury to the joint cartilage, thus making it impossible to
perform a marginal resection surgery—ie, a case for which
an ample resection with the placement of an endoprosthesis
was advisable.
RESULTS
All 214 patients were followed from 2 to 24 years (an
average of 10.6 years). The complications were: local re-
currence (19 cases, 9%), which were reoperated on with
cementation); infection (12 cases, 6%), which were revised
and rated good (8 cases) and poor (4 cases); pathologic frac-
ture (11 cases, 5%), which were rated fair in the functional
evaluation; and late osteoarthrosis (25 cases, 12%), most
of them corresponding to the cases classified as grade III
according to Campanacci’s system).
The results, according to the MSTS functional evalua-
tion system, were as follows (Figure 5):
Excellent: 166 (78%)
Good: 26 (12%)
Fair: 11 (5%)
Poor: 11 (5%)
No deaths occurred during the evaluation period.
It was not possible to perform a complete follow-up of
all patients, mainly on account of difficulties relating to
the update of medical records of patients in out Institution..
DISCUSSION
The use of local adjuvants in the management of ag-
gressive benign bone lesions is now well defined, particu-
larly for giant cell tumors. Liquid nitrogen, phenol, and
methylmethacrylate are the most commonly employed
methods, decreasing the overall recurrence rate to 9%.
Although there is some controversy as to whether the
heat generated by the polymerization is enough to destroy
tumor cells6,12,15–19 many authors have already demonstrated
that the recurrence rate is similar to other local procedures.5
The advantages of using cement include less morbidity and
postoperative complications, avoidance of unnecessary
bone autograft, earlier detection of recurrence, and imme-
diate recovery without functional deficit. Our department
has used cauterization of the inner walls of the cavity along
with cement since 1974, because we believe that it can in-
crease the necrosis depth up to 2 mm (Figure 5). We be-
lieve that another important aspect to be considered for suc-
cess in the use of cement is that it fills the cavity uniformly
and completely, without any empty spaces, possibly con-
tributing to the reduced incidence of recurrence; this does
not happen when the cavity is filled with bone graft.
Regarding complications, we had a number of cases of
pathologic fracture; most of them with large, grade III le-
sions with cortical rupture. They were reoperated on with-
out the necessity of cement removal, and the functional end
Figure 4 - A) Giant cell tumor of proximal tibia. B) Pos-operative radiography
Figure 5 - Functional result
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result was fair., Infections were superficial, and in none of
them was it necessary to perform a radical procedure, but
rather only a surgical revision, with good outcome.
We elected this technique even in cases of large lesions,
classified as grade III (25 patients), instead of performing
major reconstructive surgery. In cases with knee involve-
ment, we believe that if the pain and the limitation of range
of motion increases after a long-term appraisal, it is always
possible to perform a surgical revision to a total knee ar-
throplasty. So far, it has not been necessary to perform a
surgical revision due to degenerative arthritis.
Notably, evidence of degenerative arthritis observed in
cases with longer follow-up (more than 15 years) was more
of a radiographic than of a clinicalnature, as patients pre-
sented only mild pain and knee effusion with some degree
of joint limitation;, functional evaluation was returned. We
cannot determine whether these cases of arthritis were due
to the cement itself or to the subchondral location of the
lesion. The 1998 MSTS functional evaluation showed no
significant difference when compared to the 1985 clinical
survey.
Although nothing was proved experimentally regarding
whether the methylmethacrylate cement objectively con-
tributed to the low rate of recurrence in this series, we feel
confident that after 24 years of experience with 214 cases,
this technique is a reliable, safe, and simple method of
treatment, not only for giant cell tumors, but also for other
aggressive benign lesions.
RESUMO
Camargo OP de, Croci AT, Oliveira CRGMC de, Baptista
AM, Caiero MT. Avaliação radiográfica e funcional de 214
lesões ósseas benignas agressivas tratadas com curetagem,
cauterização e cimentação: 24 anos de seguimento. Clin-
ics. 2005; 60(6):439-44.
OBJETIVO: O tratamento com curetagem cauterização e
metilmetacrilato de lesões ósseas benignas agressivas é o
método agora amplamente aceito em quase todos os
Centros Ortopédicos Oncológicos, entretanto uma das
controvérsias com relação a esta técnica são as possíveis
complicações que podem sugerir com o uso do
metilmetacrilato fazendo com que alguns autores o
removam dos anos depois da cirurgia e os substituam com
o enxerto ósseo. O objetivo deste trabalho é apresentar a
avaliação radiográfica e funcional de 214 pacientes
apresentando lesões ósseas benignas agressivas tratadas
com curetagem, cauterização e metilmetacrilato de 1974
a 1998, sendo que alguns deles tem 12 anos de seguimento.
Esses pacientes foram avaliados clínica e radiograficamente
para a ocorrência de osteoartrose tardia, amplitude de
movimento e dor na articulação envolvida.
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